InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annu...( LOS ALTOS Calif. May 28 /- InteKrin T...),Health
Navigation Links
| HOME >> MEDICINE >> TECHNOLOGY |
InteKrin Therapeutics to Present at the 2009 American Diabetes Association Annual Meeting
Date:5/28/2009
LOS ALTOS, Calif., May 28 /PRNewswire/ -- InteKrin Therapeutics, Inc. announced today it will present Phase 2a clinical data for INT131, a Selective PPAR Modulator (SPPARM), at the American Diabetes Association annual meeting in New Orleans Saturday, June 6, 2009 during the "Novel Diabetes Therapies in Development in Humans" session at 4:00 pm CDT.
Dr. Alex DePaoli, Chief Medical Officer of InteKrin Therapeutics, will provide a summary of the latest clinical data supporting the design of INT131 to safely and effectively address insulin resistance in a presentation entitled "INT131: Significantly Lowers Glucose Without Typical Thiazolidinedione (TZD) Side Effects in Patients with Type 2 Diabetes."
About INT131
INT131 is a next-generation insulin sensitizer currently in Phase 2b testing that addresses insulin resistance, a key etiological feature in the onset and subsequent progression of type 2 diabetes. Purposefully designed as a SPPARM, INT131 selectively modulates PPAR-gamma, thereby allowing the retention of the clinically proven anti-diabetic efficacy of PPAR gamma activation, while mitigating or eliminating the well recognized side effects of TZD full PPAR gamma agonists rosiglitazone and pioglitazone (Avandia(R) and Actos(R) respectively).
About InteKrin (www.InteKrin.com)
InteKrin Therapeutics is a privately-held clinical-stage drug development company focused on diabetes, obesity and metabolic disease. InteKrin's business strategy is to build a robust portfolio of high value products by in-licensing clinical-stage therapeutic candidates that address significant unmet medical needs and rapidly move them through critical development stages. InteKrin's team of world-class scientific and medical experts includes veterans from several successful BioPharma organizations, internationally recognized experts in nuclear receptors and me
'/>"/>
| SOURCE InteKrin Therapeutics, Inc. Copyright©2009 PR Newswire. All rights reserved |
Related medicine technology :
1. InteKrin Therapeutics Announces Enrollment Completion of 360 Patient, 24 week Phase 2b Study
2. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
3. Fate Therapeutics Announces First Patient Treated in Phase 1b Clinical Trial of FT1050 for Hematopoietic Stem Cell Support
4. Ascenta Therapeutics Announces Multiple Presentations on AT-101 at 2009 ASCO Annual Meeting
5. Oxford BioTherapeutics and GlaxoSmithKline Form Strategic Alliance to Develop Novel Cancer Therapeutic Antibodies
6. FDA Accepts Arno Therapeutics IND for AR-12 a PDK1 Inhibitor That Blocks the PI3K/Akt Pathway
7. Logical Therapeutics Appoints Peter A. Lankau as CEO and Director
8. Arcion Therapeutics Topical Pain Candidate, ARC-4558, Significantly Reduces Pain Caused by Diabetic Neuropathy
9. Trius Therapeutics Announces Presentations Featuring Torezolid Antibiotic at the 19th European Congress of Clinical Microbiology and Infectious Diseases
10. Hyperion Therapeutics Receives Orphan Drug Designation for HPN-100 for the Treatment of Urea Cycle Disorders
11. Sirion Therapeutics Announces Clinical Data Presentations at the 2009 Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting
Post Your Comments:
(Date:11/24/2009)...-ChindexInternational,Inc.,("Chindex")(Nasdaq: CHD...ealthcareproductsandservicesinthePeople,sRepublico...1stAnnualPiperJaffray,"Unplugged"HealthCareConfere...tel. , Managementiscurrentlyscheduledtopresen...n-onemeetingsthroughouttheday.Awebcast,ofthepresen...
(Date:11/24/2009)...all/--QuestDiagnosticsIncorporated(NYSE: DGX ),the...ionandservices,announcedthatitisscheduledtospeakat...YorkCity.ThepresentationisscheduledforWednesday,De...conference,thecompanywillreaffirmits2009guidancefo...eed18%ofrevenues,anddilutedearningspersharefromcon...
(Date:11/24/2009)...RNewswire/-- EisaiInc.andPfizerIncannouncedtodayt...dforreviewEisai,sNewDrugApplication(NDA)foroncedai...bletsforthetreatmentofmoderatetosevereAlzheimer,sd...gofdonepezilHClinanextendedrelease,matrix-typetabl...thedrug.TheNDAisbasedonahead-to-headclinicalstudyc...
Breaking Medicine Technology:Chindex International to Present at Piper Jaffray Health Care Conference 2Quest Diagnostics To Speak At The 21st Annual Piper Jaffray Healthcare Conference 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Volcano Corporation Presentation At Canaccord Adams Conference To Be Webcast 13452 1Volcano Corporation Presentation At Canaccord Adams Conference To Be Webcast 13452 2Novavax Reports Second Quarter 2009 Financial Results 13450 1Novavax Reports Second Quarter 2009 Financial Results 13450 2Novavax Reports Second Quarter 2009 Financial Results 13450 3Novavax Reports Second Quarter 2009 Financial Results 13450 4Novavax Reports Second Quarter 2009 Financial Results 13450 5Novavax Reports Second Quarter 2009 Financial Results 13450 6Novavax Reports Second Quarter 2009 Financial Results 13450 7Novavax Reports Second Quarter 2009 Financial Results 13450 8Novavax Reports Second Quarter 2009 Financial Results 13450 9More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 1More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 2More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 3More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 4More Than 100 Healthy Schools Honored by the Alliance for a Healthier Generation 53936 5...ceuticals (, http://www.addrenex.com ) has made t...l of identifying and developing as many new drug c...he fast-paced timeline they have set for drug disc...veloping two new drugs, Clonicel(R) for,attention ...pertension,over the past two years. A new drug app...
...CEUTICALS, INC. (Pink Sheets: VION) announced toda...utch-Belgian Cooperative Trial Group,for Hematolog...al of,laromustine (Cloretazine(R) (VNP40101M)) wit... aged 18-65 with previously untreated acute myelog...(MDS)., Alan Kessman, Chief Executive Officer, co...
Other Medicine Technology:Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 2Addrenex Pharmaceuticals' New Hires Further Company Goal to Identify New Drugs for Adrenergic Regulation 3Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3(Date:11/25/2009)... Nationwide Imaging Services, known ...ons for diagnostic imaging equipment, now offering...ing financing options, service and installation wi...Medical Technologies of California) , ...- Nationwide Imaging Services is proud to announce...
(Date:11/25/2009)...CLEMENS,Mich.,Nov.25/PRNewswire/--TwomoreH1N1vacci...rday,Dec.5,theMacombCountyHealthDepartmentannounce...ceatFreedomHillCountyParkinSterlingHeights. ,, ...ewillrunfrom9a.m.to3p.m.Thethimerosol-freeversiono...ilesupplieslast.Bothinjectableandnasalsprayimmuniz...
(Date:11/25/2009)... - Two signaling pathways essential to normal huma...al growth factor receptor (EGFR) pathways - intera...d metastasis, researchers from The University of T...v. 25 issue of Molecular Cell . , This newly ch...omponents known to correlate with invasive cancer ...
(Date:11/25/2009)...ease is available in French . , An innovati...University Health Centre researchers has passed it...w approach is an immunotherapy customized for each... Routy from the Research Institute of the MUHC in ... de Montral. "This is a vaccine made for the indiv...
(Date:11/25/2009)... offer waistline-friendly ways to enjoy festive fe... News) -- If you love the five-week holiday smorga...eady stressing about the added pounds you,ll have ...,s possible, say nutrition experts, to enjoy holid...as you do today. , It,s all about devising a s...
Breaking Medicine News(10 mins):Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 2Health News:Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) 3Health News:Macomb County Health Department Schedules Two More H1N1 Flu Vaccine Clinics Dec. 3 and 5 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 2Health News:Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis 3Health News:Tailor-made HIV/AIDS treatment closer to reality 2Health News:Holiday Eating Without the Guilt -- or the Pounds 2Health News:Holiday Eating Without the Guilt -- or the Pounds 3[0] Nationwide Imaging Services, Inc., Leader In Diagnostic Imaging Equipment, Announces Acquisition Of Kosmic Medical, Inc. (dba Atlas Medical Technologies of California) [0] Macomb County Health Department Schedules Two More H1N1 Flu Vaccine Clinics Dec. 3 and 5[0] Crosstalk between critical cell-signaling pathways holds clues to tumor invasion and metastasis[0] Tailor-made HIV/AIDS treatment closer to reality[0] Holiday Eating Without the Guilt -- or the Pounds
...The United Nations has launched a coordinated acti...tive health of women across the globe.//
The...UNFPA) comes in the wake of estimates that more th... worrying rise in the number and severity of sexua...
...Hormones do not cause pre-menstrual tension and po...t, according to a leading women's health expert //... Sydney. She wants to bring about a change in the ... than a medical illness. Post-natal depression and...
...Finally there is some scientific research to expla...gs that seem to be said in a perfectly audible vol... what seems like a reasonable volume to them is so...e House Ear Institute in Los Angeles has said that...
...In a move to ensure all NHS patients get the oppor...ernment is introducing a system of random checks /...with the appointment times.
The official fig...ents' actual experiences. Critics do argue that th...
...US research have suggested that an electronic devi...rts, explaining that the hand-held device creates ...pts' the migraine. //
Researchers have expla...researchers from the UK have cautioned that though...
...The Ontario government is tackling obesity by aimi... to eat their vegetables. //
According to Heal...would be launching a pilot project this fall, wher... goal is, if successful, I'd like to see it stretc...
Other Medicine News:Health News:GP's discontented with 48-hour target 2Health News:Researchers Develop An Electric Device For Relief From Migraine 2Health News:Obesity Tackled at School Level 2| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |